Global Ophthalmic Drug Delivery Device Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Ophthalmic Drug Delivery Device market size was estimated at USD 178.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Ophthalmic Drug Delivery Device market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Ophthalmic Drug Delivery Device market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Ophthalmic Drug Delivery Device market.
Global Ophthalmic Drug Delivery Device Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Market Segmentation (by Type)
Pre-Filled Syringes
Multidose Eyedroppers
Squeeze Dispenser
Mist Sprayers
Add-On Devices
Contact Lenses
Others
Market Segmentation (by Application)
Hospitals
Clinics
Homecare
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Ophthalmic Drug Delivery Device Market
Overview of the regional outlook of the Ophthalmic Drug Delivery Device Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Ophthalmic Drug Delivery Device Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Ophthalmic Drug Delivery Device, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Ophthalmic Drug Delivery Device market size was estimated at USD 178.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 4.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Ophthalmic Drug Delivery Device market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Ophthalmic Drug Delivery Device market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Ophthalmic Drug Delivery Device market.
Global Ophthalmic Drug Delivery Device Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Market Segmentation (by Type)
Pre-Filled Syringes
Multidose Eyedroppers
Squeeze Dispenser
Mist Sprayers
Add-On Devices
Contact Lenses
Others
Market Segmentation (by Application)
Hospitals
Clinics
Homecare
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Ophthalmic Drug Delivery Device Market
Overview of the regional outlook of the Ophthalmic Drug Delivery Device Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Ophthalmic Drug Delivery Device Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Ophthalmic Drug Delivery Device, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Ophthalmic Drug Delivery Device
1.2 Key Market Segments
1.2.1 Ophthalmic Drug Delivery Device Segment by Type
1.2.2 Ophthalmic Drug Delivery Device Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPHTHALMIC DRUG DELIVERY DEVICE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Ophthalmic Drug Delivery Device Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Ophthalmic Drug Delivery Device Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPHTHALMIC DRUG DELIVERY DEVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Ophthalmic Drug Delivery Device Product Life Cycle
3.3 Global Ophthalmic Drug Delivery Device Sales by Manufacturers (2020-2025)
3.4 Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
3.5 Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Ophthalmic Drug Delivery Device Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Ophthalmic Drug Delivery Device Market Competitive Situation and Trends
3.8.1 Ophthalmic Drug Delivery Device Market Concentration Rate
3.8.2 Global 5 and 10 Largest Ophthalmic Drug Delivery Device Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OPHTHALMIC DRUG DELIVERY DEVICE INDUSTRY CHAIN ANALYSIS
4.1 Ophthalmic Drug Delivery Device Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPHTHALMIC DRUG DELIVERY DEVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Ophthalmic Drug Delivery Device Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Ophthalmic Drug Delivery Device Market
5.7 ESG Ratings of Leading Companies
6 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2025)
6.3 Global Ophthalmic Drug Delivery Device Market Size by Type (2020-2025)
6.4 Global Ophthalmic Drug Delivery Device Price by Type (2020-2025)
7 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Ophthalmic Drug Delivery Device Market Sales by Application (2020-2025)
7.3 Global Ophthalmic Drug Delivery Device Market Size (M USD) by Application (2020-2025)
7.4 Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
8 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SALES BY REGION
8.1 Global Ophthalmic Drug Delivery Device Sales by Region
8.1.1 Global Ophthalmic Drug Delivery Device Sales by Region
8.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Region
8.2 Global Ophthalmic Drug Delivery Device Market Size by Region
8.2.1 Global Ophthalmic Drug Delivery Device Market Size by Region
8.2.2 Global Ophthalmic Drug Delivery Device Market Size by Region
8.3 North America
8.3.1 North America Ophthalmic Drug Delivery Device Sales by Country
8.3.2 North America Ophthalmic Drug Delivery Device Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Ophthalmic Drug Delivery Device Sales by Country
8.4.2 Europe Ophthalmic Drug Delivery Device Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Ophthalmic Drug Delivery Device Sales by Region
8.5.2 Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Ophthalmic Drug Delivery Device Sales by Country
8.6.2 South America Ophthalmic Drug Delivery Device Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Region
8.7.2 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OPHTHALMIC DRUG DELIVERY DEVICE MARKET PRODUCTION BY REGION
9.1 Global Production of Ophthalmic Drug Delivery Device by Region(2020-2025)
9.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2025)
9.3 Global Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Ophthalmic Drug Delivery Device Production
9.4.1 North America Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.4.2 North America Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Ophthalmic Drug Delivery Device Production
9.5.1 Europe Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.5.2 Europe Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Ophthalmic Drug Delivery Device Production (2020-2025)
9.6.1 Japan Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.6.2 Japan Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Ophthalmic Drug Delivery Device Production (2020-2025)
9.7.1 China Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.7.2 China Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Aero Pump GmbH
10.1.1 Aero Pump GmbH Basic Information
10.1.2 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Overview
10.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Market Performance
10.1.4 Aero Pump GmbH Business Overview
10.1.5 Aero Pump GmbH SWOT Analysis
10.1.6 Aero Pump GmbH Recent Developments
10.2 AptarGroup
10.2.1 AptarGroup Basic Information
10.2.2 AptarGroup Ophthalmic Drug Delivery Device Product Overview
10.2.3 AptarGroup Ophthalmic Drug Delivery Device Product Market Performance
10.2.4 AptarGroup Business Overview
10.2.5 AptarGroup SWOT Analysis
10.2.6 AptarGroup Recent Developments
10.3 Bausch Health
10.3.1 Bausch Health Basic Information
10.3.2 Bausch Health Ophthalmic Drug Delivery Device Product Overview
10.3.3 Bausch Health Ophthalmic Drug Delivery Device Product Market Performance
10.3.4 Bausch Health Business Overview
10.3.5 Bausch Health SWOT Analysis
10.3.6 Bausch Health Recent Developments
10.4 Becton Dickinson and Company
10.4.1 Becton Dickinson and Company Basic Information
10.4.2 Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Overview
10.4.3 Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Market Performance
10.4.4 Becton Dickinson and Company Business Overview
10.4.5 Becton Dickinson and Company Recent Developments
10.5 EyePoint Pharmaceuticals, Inc.
10.5.1 EyePoint Pharmaceuticals, Inc. Basic Information
10.5.2 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Overview
10.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.5.4 EyePoint Pharmaceuticals, Inc. Business Overview
10.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments
10.6 Gaplast GmbH
10.6.1 Gaplast GmbH Basic Information
10.6.2 Gaplast GmbH Ophthalmic Drug Delivery Device Product Overview
10.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Product Market Performance
10.6.4 Gaplast GmbH Business Overview
10.6.5 Gaplast GmbH Recent Developments
10.7 Gerresheimer
10.7.1 Gerresheimer Basic Information
10.7.2 Gerresheimer Ophthalmic Drug Delivery Device Product Overview
10.7.3 Gerresheimer Ophthalmic Drug Delivery Device Product Market Performance
10.7.4 Gerresheimer Business Overview
10.7.5 Gerresheimer Recent Developments
10.8 Nemera
10.8.1 Nemera Basic Information
10.8.2 Nemera Ophthalmic Drug Delivery Device Product Overview
10.8.3 Nemera Ophthalmic Drug Delivery Device Product Market Performance
10.8.4 Nemera Business Overview
10.8.5 Nemera Recent Developments
10.9 Nipro Corporation
10.9.1 Nipro Corporation Basic Information
10.9.2 Nipro Corporation Ophthalmic Drug Delivery Device Product Overview
10.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Product Market Performance
10.9.4 Nipro Corporation Business Overview
10.9.5 Nipro Corporation Recent Developments
10.10 Ocular Therapeutix
10.10.1 Ocular Therapeutix Basic Information
10.10.2 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Overview
10.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Market Performance
10.10.4 Ocular Therapeutix Business Overview
10.10.5 Ocular Therapeutix Recent Developments
10.11 Owen Mumford
10.11.1 Owen Mumford Basic Information
10.11.2 Owen Mumford Ophthalmic Drug Delivery Device Product Overview
10.11.3 Owen Mumford Ophthalmic Drug Delivery Device Product Market Performance
10.11.4 Owen Mumford Business Overview
10.11.5 Owen Mumford Recent Developments
10.12 Silgan Holdings Inc.
10.12.1 Silgan Holdings Inc. Basic Information
10.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Overview
10.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.12.4 Silgan Holdings Inc. Business Overview
10.12.5 Silgan Holdings Inc. Recent Developments
10.13 Terumo Corporation
10.13.1 Terumo Corporation Basic Information
10.13.2 Terumo Corporation Ophthalmic Drug Delivery Device Product Overview
10.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Product Market Performance
10.13.4 Terumo Corporation Business Overview
10.13.5 Terumo Corporation Recent Developments
10.14 West Pharmaceutical Services, Inc.
10.14.1 West Pharmaceutical Services, Inc. Basic Information
10.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Overview
10.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.14.4 West Pharmaceutical Services, Inc. Business Overview
10.14.5 West Pharmaceutical Services, Inc. Recent Developments
10.15 Kedalion Therapeutics
10.15.1 Kedalion Therapeutics Basic Information
10.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Overview
10.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Market Performance
10.15.4 Kedalion Therapeutics Business Overview
10.15.5 Kedalion Therapeutics Recent Developments
10.16 Re-Vana Therapeutics
10.16.1 Re-Vana Therapeutics Basic Information
10.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Overview
10.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Market Performance
10.16.4 Re-Vana Therapeutics Business Overview
10.16.5 Re-Vana Therapeutics Recent Developments
10.17 Mati Therapeutics, Inc.,
10.17.1 Mati Therapeutics, Inc., Basic Information
10.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Overview
10.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Market Performance
10.17.4 Mati Therapeutics, Inc., Business Overview
10.17.5 Mati Therapeutics, Inc., Recent Developments
10.18 Biocorp Production
10.18.1 Biocorp Production Basic Information
10.18.2 Biocorp Production Ophthalmic Drug Delivery Device Product Overview
10.18.3 Biocorp Production Ophthalmic Drug Delivery Device Product Market Performance
10.18.4 Biocorp Production Business Overview
10.18.5 Biocorp Production Recent Developments
10.19 Ocumedic, Inc.
10.19.1 Ocumedic, Inc. Basic Information
10.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Overview
10.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.19.4 Ocumedic, Inc. Business Overview
10.19.5 Ocumedic, Inc. Recent Developments
11 OPHTHALMIC DRUG DELIVERY DEVICE MARKET FORECAST BY REGION
11.1 Global Ophthalmic Drug Delivery Device Market Size Forecast
11.2 Global Ophthalmic Drug Delivery Device Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country
11.2.3 Asia Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Region
11.2.4 South America Ophthalmic Drug Delivery Device Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Ophthalmic Drug Delivery Device by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Ophthalmic Drug Delivery Device Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Ophthalmic Drug Delivery Device by Type (2026-2035)
12.1.2 Global Ophthalmic Drug Delivery Device Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Ophthalmic Drug Delivery Device by Type (2026-2035)
12.2 Global Ophthalmic Drug Delivery Device Market Forecast by Application (2026-2035)
12.2.1 Global Ophthalmic Drug Delivery Device Sales (K Units) Forecast by Application
12.2.2 Global Ophthalmic Drug Delivery Device Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Ophthalmic Drug Delivery Device
1.2 Key Market Segments
1.2.1 Ophthalmic Drug Delivery Device Segment by Type
1.2.2 Ophthalmic Drug Delivery Device Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 OPHTHALMIC DRUG DELIVERY DEVICE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Ophthalmic Drug Delivery Device Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Ophthalmic Drug Delivery Device Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 OPHTHALMIC DRUG DELIVERY DEVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Ophthalmic Drug Delivery Device Product Life Cycle
3.3 Global Ophthalmic Drug Delivery Device Sales by Manufacturers (2020-2025)
3.4 Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2020-2025)
3.5 Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Ophthalmic Drug Delivery Device Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Ophthalmic Drug Delivery Device Market Competitive Situation and Trends
3.8.1 Ophthalmic Drug Delivery Device Market Concentration Rate
3.8.2 Global 5 and 10 Largest Ophthalmic Drug Delivery Device Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 OPHTHALMIC DRUG DELIVERY DEVICE INDUSTRY CHAIN ANALYSIS
4.1 Ophthalmic Drug Delivery Device Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF OPHTHALMIC DRUG DELIVERY DEVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Ophthalmic Drug Delivery Device Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Ophthalmic Drug Delivery Device Market
5.7 ESG Ratings of Leading Companies
6 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2025)
6.3 Global Ophthalmic Drug Delivery Device Market Size by Type (2020-2025)
6.4 Global Ophthalmic Drug Delivery Device Price by Type (2020-2025)
7 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Ophthalmic Drug Delivery Device Market Sales by Application (2020-2025)
7.3 Global Ophthalmic Drug Delivery Device Market Size (M USD) by Application (2020-2025)
7.4 Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
8 OPHTHALMIC DRUG DELIVERY DEVICE MARKET SALES BY REGION
8.1 Global Ophthalmic Drug Delivery Device Sales by Region
8.1.1 Global Ophthalmic Drug Delivery Device Sales by Region
8.1.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Region
8.2 Global Ophthalmic Drug Delivery Device Market Size by Region
8.2.1 Global Ophthalmic Drug Delivery Device Market Size by Region
8.2.2 Global Ophthalmic Drug Delivery Device Market Size by Region
8.3 North America
8.3.1 North America Ophthalmic Drug Delivery Device Sales by Country
8.3.2 North America Ophthalmic Drug Delivery Device Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Ophthalmic Drug Delivery Device Sales by Country
8.4.2 Europe Ophthalmic Drug Delivery Device Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Ophthalmic Drug Delivery Device Sales by Region
8.5.2 Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Ophthalmic Drug Delivery Device Sales by Country
8.6.2 South America Ophthalmic Drug Delivery Device Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Ophthalmic Drug Delivery Device Sales by Region
8.7.2 Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 OPHTHALMIC DRUG DELIVERY DEVICE MARKET PRODUCTION BY REGION
9.1 Global Production of Ophthalmic Drug Delivery Device by Region(2020-2025)
9.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2025)
9.3 Global Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Ophthalmic Drug Delivery Device Production
9.4.1 North America Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.4.2 North America Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Ophthalmic Drug Delivery Device Production
9.5.1 Europe Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.5.2 Europe Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Ophthalmic Drug Delivery Device Production (2020-2025)
9.6.1 Japan Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.6.2 Japan Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Ophthalmic Drug Delivery Device Production (2020-2025)
9.7.1 China Ophthalmic Drug Delivery Device Production Growth Rate (2020-2025)
9.7.2 China Ophthalmic Drug Delivery Device Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Aero Pump GmbH
10.1.1 Aero Pump GmbH Basic Information
10.1.2 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Overview
10.1.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Market Performance
10.1.4 Aero Pump GmbH Business Overview
10.1.5 Aero Pump GmbH SWOT Analysis
10.1.6 Aero Pump GmbH Recent Developments
10.2 AptarGroup
10.2.1 AptarGroup Basic Information
10.2.2 AptarGroup Ophthalmic Drug Delivery Device Product Overview
10.2.3 AptarGroup Ophthalmic Drug Delivery Device Product Market Performance
10.2.4 AptarGroup Business Overview
10.2.5 AptarGroup SWOT Analysis
10.2.6 AptarGroup Recent Developments
10.3 Bausch Health
10.3.1 Bausch Health Basic Information
10.3.2 Bausch Health Ophthalmic Drug Delivery Device Product Overview
10.3.3 Bausch Health Ophthalmic Drug Delivery Device Product Market Performance
10.3.4 Bausch Health Business Overview
10.3.5 Bausch Health SWOT Analysis
10.3.6 Bausch Health Recent Developments
10.4 Becton Dickinson and Company
10.4.1 Becton Dickinson and Company Basic Information
10.4.2 Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Overview
10.4.3 Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Market Performance
10.4.4 Becton Dickinson and Company Business Overview
10.4.5 Becton Dickinson and Company Recent Developments
10.5 EyePoint Pharmaceuticals, Inc.
10.5.1 EyePoint Pharmaceuticals, Inc. Basic Information
10.5.2 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Overview
10.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.5.4 EyePoint Pharmaceuticals, Inc. Business Overview
10.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments
10.6 Gaplast GmbH
10.6.1 Gaplast GmbH Basic Information
10.6.2 Gaplast GmbH Ophthalmic Drug Delivery Device Product Overview
10.6.3 Gaplast GmbH Ophthalmic Drug Delivery Device Product Market Performance
10.6.4 Gaplast GmbH Business Overview
10.6.5 Gaplast GmbH Recent Developments
10.7 Gerresheimer
10.7.1 Gerresheimer Basic Information
10.7.2 Gerresheimer Ophthalmic Drug Delivery Device Product Overview
10.7.3 Gerresheimer Ophthalmic Drug Delivery Device Product Market Performance
10.7.4 Gerresheimer Business Overview
10.7.5 Gerresheimer Recent Developments
10.8 Nemera
10.8.1 Nemera Basic Information
10.8.2 Nemera Ophthalmic Drug Delivery Device Product Overview
10.8.3 Nemera Ophthalmic Drug Delivery Device Product Market Performance
10.8.4 Nemera Business Overview
10.8.5 Nemera Recent Developments
10.9 Nipro Corporation
10.9.1 Nipro Corporation Basic Information
10.9.2 Nipro Corporation Ophthalmic Drug Delivery Device Product Overview
10.9.3 Nipro Corporation Ophthalmic Drug Delivery Device Product Market Performance
10.9.4 Nipro Corporation Business Overview
10.9.5 Nipro Corporation Recent Developments
10.10 Ocular Therapeutix
10.10.1 Ocular Therapeutix Basic Information
10.10.2 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Overview
10.10.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Market Performance
10.10.4 Ocular Therapeutix Business Overview
10.10.5 Ocular Therapeutix Recent Developments
10.11 Owen Mumford
10.11.1 Owen Mumford Basic Information
10.11.2 Owen Mumford Ophthalmic Drug Delivery Device Product Overview
10.11.3 Owen Mumford Ophthalmic Drug Delivery Device Product Market Performance
10.11.4 Owen Mumford Business Overview
10.11.5 Owen Mumford Recent Developments
10.12 Silgan Holdings Inc.
10.12.1 Silgan Holdings Inc. Basic Information
10.12.2 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Overview
10.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.12.4 Silgan Holdings Inc. Business Overview
10.12.5 Silgan Holdings Inc. Recent Developments
10.13 Terumo Corporation
10.13.1 Terumo Corporation Basic Information
10.13.2 Terumo Corporation Ophthalmic Drug Delivery Device Product Overview
10.13.3 Terumo Corporation Ophthalmic Drug Delivery Device Product Market Performance
10.13.4 Terumo Corporation Business Overview
10.13.5 Terumo Corporation Recent Developments
10.14 West Pharmaceutical Services, Inc.
10.14.1 West Pharmaceutical Services, Inc. Basic Information
10.14.2 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Overview
10.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.14.4 West Pharmaceutical Services, Inc. Business Overview
10.14.5 West Pharmaceutical Services, Inc. Recent Developments
10.15 Kedalion Therapeutics
10.15.1 Kedalion Therapeutics Basic Information
10.15.2 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Overview
10.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Market Performance
10.15.4 Kedalion Therapeutics Business Overview
10.15.5 Kedalion Therapeutics Recent Developments
10.16 Re-Vana Therapeutics
10.16.1 Re-Vana Therapeutics Basic Information
10.16.2 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Overview
10.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Market Performance
10.16.4 Re-Vana Therapeutics Business Overview
10.16.5 Re-Vana Therapeutics Recent Developments
10.17 Mati Therapeutics, Inc.,
10.17.1 Mati Therapeutics, Inc., Basic Information
10.17.2 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Overview
10.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Market Performance
10.17.4 Mati Therapeutics, Inc., Business Overview
10.17.5 Mati Therapeutics, Inc., Recent Developments
10.18 Biocorp Production
10.18.1 Biocorp Production Basic Information
10.18.2 Biocorp Production Ophthalmic Drug Delivery Device Product Overview
10.18.3 Biocorp Production Ophthalmic Drug Delivery Device Product Market Performance
10.18.4 Biocorp Production Business Overview
10.18.5 Biocorp Production Recent Developments
10.19 Ocumedic, Inc.
10.19.1 Ocumedic, Inc. Basic Information
10.19.2 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Overview
10.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Market Performance
10.19.4 Ocumedic, Inc. Business Overview
10.19.5 Ocumedic, Inc. Recent Developments
11 OPHTHALMIC DRUG DELIVERY DEVICE MARKET FORECAST BY REGION
11.1 Global Ophthalmic Drug Delivery Device Market Size Forecast
11.2 Global Ophthalmic Drug Delivery Device Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country
11.2.3 Asia Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Region
11.2.4 South America Ophthalmic Drug Delivery Device Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Ophthalmic Drug Delivery Device by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Ophthalmic Drug Delivery Device Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Ophthalmic Drug Delivery Device by Type (2026-2035)
12.1.2 Global Ophthalmic Drug Delivery Device Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Ophthalmic Drug Delivery Device by Type (2026-2035)
12.2 Global Ophthalmic Drug Delivery Device Market Forecast by Application (2026-2035)
12.2.1 Global Ophthalmic Drug Delivery Device Sales (K Units) Forecast by Application
12.2.2 Global Ophthalmic Drug Delivery Device Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Ophthalmic Drug Delivery Device Market Size by Type (M USD)
Table 4. Global Ophthalmic Drug Delivery Device Market Size by Application
Table 5. Ophthalmic Drug Delivery Device Market Size Comparison by Region (M USD)
Table 6. Global Ophthalmic Drug Delivery Device Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Ophthalmic Drug Delivery Device Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drug Delivery Device as of 2025)
Table 11. Global Market Ophthalmic Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Ophthalmic Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Ophthalmic Drug Delivery Device Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Ophthalmic Drug Delivery Device Sales by Type (K Units)
Table 27. Global Ophthalmic Drug Delivery Device Market Size by Type (M USD)
Table 28. Global Ophthalmic Drug Delivery Device Sales (K Units) by Type (2020-2025)
Table 29. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2025)
Table 30. Global Ophthalmic Drug Delivery Device Market Size (M USD) by Type (2020-2025)
Table 31. Global Ophthalmic Drug Delivery Device Market Share by Type (2020-2025)
Table 32. Global Ophthalmic Drug Delivery Device Price (USD/Unit) by Type (2020-2025)
Table 33. Global Ophthalmic Drug Delivery Device Sales (K Units) by Application
Table 34. Global Ophthalmic Drug Delivery Device Market Size by Application
Table 35. Global Ophthalmic Drug Delivery Device Sales by Application (2020-2025) & (K Units)
Table 36. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2025)
Table 37. Global Ophthalmic Drug Delivery Device Market Size by Application (2020-2025) & (M USD)
Table 38. Global Ophthalmic Drug Delivery Device Market Share by Application (2020-2025)
Table 39. Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
Table 40. Global Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 41. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2025)
Table 42. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 43. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025)
Table 44. North America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 45. North America Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 47. Europe Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 50. South America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 51. South America Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 54. Global Ophthalmic Drug Delivery Device Production (K Units) by Region(2020-2025)
Table 55. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2025)
Table 57. Global Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Aero Pump GmbH Basic Information
Table 63. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Overview
Table 64. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Aero Pump GmbH Business Overview
Table 66. Aero Pump GmbH SWOT Analysis
Table 67. Aero Pump GmbH Recent Developments
Table 68. AptarGroup Basic Information
Table 69. AptarGroup Ophthalmic Drug Delivery Device Product Overview
Table 70. AptarGroup Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. AptarGroup Business Overview
Table 72. AptarGroup SWOT Analysis
Table 73. AptarGroup Recent Developments
Table 74. Bausch Health Basic Information
Table 75. Bausch Health Ophthalmic Drug Delivery Device Product Overview
Table 76. Bausch Health Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bausch Health Business Overview
Table 78. Bausch Health SWOT Analysis
Table 79. Bausch Health Recent Developments
Table 80. Becton Dickinson and Company Basic Information
Table 81. Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Overview
Table 82. Becton Dickinson and Company Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Becton Dickinson and Company Business Overview
Table 84. Becton Dickinson and Company Recent Developments
Table 85. EyePoint Pharmaceuticals, Inc. Basic Information
Table 86. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 87. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. EyePoint Pharmaceuticals, Inc. Business Overview
Table 89. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 90. Gaplast GmbH Basic Information
Table 91. Gaplast GmbH Ophthalmic Drug Delivery Device Product Overview
Table 92. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gaplast GmbH Business Overview
Table 94. Gaplast GmbH Recent Developments
Table 95. Gerresheimer Basic Information
Table 96. Gerresheimer Ophthalmic Drug Delivery Device Product Overview
Table 97. Gerresheimer Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gerresheimer Business Overview
Table 99. Gerresheimer Recent Developments
Table 100. Nemera Basic Information
Table 101. Nemera Ophthalmic Drug Delivery Device Product Overview
Table 102. Nemera Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Nemera Business Overview
Table 104. Nemera Recent Developments
Table 105. Nipro Corporation Basic Information
Table 106. Nipro Corporation Ophthalmic Drug Delivery Device Product Overview
Table 107. Nipro Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nipro Corporation Business Overview
Table 109. Nipro Corporation Recent Developments
Table 110. Ocular Therapeutix Basic Information
Table 111. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Overview
Table 112. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Ocular Therapeutix Business Overview
Table 114. Ocular Therapeutix Recent Developments
Table 115. Owen Mumford Basic Information
Table 116. Owen Mumford Ophthalmic Drug Delivery Device Product Overview
Table 117. Owen Mumford Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Owen Mumford Business Overview
Table 119. Owen Mumford Recent Developments
Table 120. Silgan Holdings Inc. Basic Information
Table 121. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Overview
Table 122. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Silgan Holdings Inc. Business Overview
Table 124. Silgan Holdings Inc. Recent Developments
Table 125. Terumo Corporation Basic Information
Table 126. Terumo Corporation Ophthalmic Drug Delivery Device Product Overview
Table 127. Terumo Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Terumo Corporation Business Overview
Table 129. Terumo Corporation Recent Developments
Table 130. West Pharmaceutical Services, Inc. Basic Information
Table 131. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 132. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. West Pharmaceutical Services, Inc. Business Overview
Table 134. West Pharmaceutical Services, Inc. Recent Developments
Table 135. Kedalion Therapeutics Basic Information
Table 136. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Overview
Table 137. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Kedalion Therapeutics Business Overview
Table 139. Kedalion Therapeutics Recent Developments
Table 140. Re-Vana Therapeutics Basic Information
Table 141. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Overview
Table 142. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Re-Vana Therapeutics Business Overview
Table 144. Re-Vana Therapeutics Recent Developments
Table 145. Mati Therapeutics, Inc., Basic Information
Table 146. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Overview
Table 147. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Mati Therapeutics, Inc., Business Overview
Table 149. Mati Therapeutics, Inc., Recent Developments
Table 150. Biocorp Production Basic Information
Table 151. Biocorp Production Ophthalmic Drug Delivery Device Product Overview
Table 152. Biocorp Production Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Biocorp Production Business Overview
Table 154. Biocorp Production Recent Developments
Table 155. Ocumedic, Inc. Basic Information
Table 156. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 157. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Ocumedic, Inc. Business Overview
Table 159. Ocumedic, Inc. Recent Developments
Table 160. Global Ophthalmic Drug Delivery Device Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Ophthalmic Drug Delivery Device Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Ophthalmic Drug Delivery Device Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Ophthalmic Drug Delivery Device Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Ophthalmic Drug Delivery Device Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Ophthalmic Drug Delivery Device Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Ophthalmic Drug Delivery Device Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Ophthalmic Drug Delivery Device Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Ophthalmic Drug Delivery Device Market Size by Type (M USD)
Table 4. Global Ophthalmic Drug Delivery Device Market Size by Application
Table 5. Ophthalmic Drug Delivery Device Market Size Comparison by Region (M USD)
Table 6. Global Ophthalmic Drug Delivery Device Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Ophthalmic Drug Delivery Device Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drug Delivery Device as of 2025)
Table 11. Global Market Ophthalmic Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Ophthalmic Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Ophthalmic Drug Delivery Device Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Ophthalmic Drug Delivery Device Sales by Type (K Units)
Table 27. Global Ophthalmic Drug Delivery Device Market Size by Type (M USD)
Table 28. Global Ophthalmic Drug Delivery Device Sales (K Units) by Type (2020-2025)
Table 29. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2020-2025)
Table 30. Global Ophthalmic Drug Delivery Device Market Size (M USD) by Type (2020-2025)
Table 31. Global Ophthalmic Drug Delivery Device Market Share by Type (2020-2025)
Table 32. Global Ophthalmic Drug Delivery Device Price (USD/Unit) by Type (2020-2025)
Table 33. Global Ophthalmic Drug Delivery Device Sales (K Units) by Application
Table 34. Global Ophthalmic Drug Delivery Device Market Size by Application
Table 35. Global Ophthalmic Drug Delivery Device Sales by Application (2020-2025) & (K Units)
Table 36. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2025)
Table 37. Global Ophthalmic Drug Delivery Device Market Size by Application (2020-2025) & (M USD)
Table 38. Global Ophthalmic Drug Delivery Device Market Share by Application (2020-2025)
Table 39. Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
Table 40. Global Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 41. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2025)
Table 42. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 43. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025)
Table 44. North America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 45. North America Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 47. Europe Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 50. South America Ophthalmic Drug Delivery Device Sales by Country (2020-2025) & (K Units)
Table 51. South America Ophthalmic Drug Delivery Device Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Ophthalmic Drug Delivery Device Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region (2020-2025) & (M USD)
Table 54. Global Ophthalmic Drug Delivery Device Production (K Units) by Region(2020-2025)
Table 55. Global Ophthalmic Drug Delivery Device Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2020-2025)
Table 57. Global Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Ophthalmic Drug Delivery Device Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Aero Pump GmbH Basic Information
Table 63. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Overview
Table 64. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Aero Pump GmbH Business Overview
Table 66. Aero Pump GmbH SWOT Analysis
Table 67. Aero Pump GmbH Recent Developments
Table 68. AptarGroup Basic Information
Table 69. AptarGroup Ophthalmic Drug Delivery Device Product Overview
Table 70. AptarGroup Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. AptarGroup Business Overview
Table 72. AptarGroup SWOT Analysis
Table 73. AptarGroup Recent Developments
Table 74. Bausch Health Basic Information
Table 75. Bausch Health Ophthalmic Drug Delivery Device Product Overview
Table 76. Bausch Health Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bausch Health Business Overview
Table 78. Bausch Health SWOT Analysis
Table 79. Bausch Health Recent Developments
Table 80. Becton Dickinson and Company Basic Information
Table 81. Becton Dickinson and Company Ophthalmic Drug Delivery Device Product Overview
Table 82. Becton Dickinson and Company Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Becton Dickinson and Company Business Overview
Table 84. Becton Dickinson and Company Recent Developments
Table 85. EyePoint Pharmaceuticals, Inc. Basic Information
Table 86. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 87. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. EyePoint Pharmaceuticals, Inc. Business Overview
Table 89. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 90. Gaplast GmbH Basic Information
Table 91. Gaplast GmbH Ophthalmic Drug Delivery Device Product Overview
Table 92. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gaplast GmbH Business Overview
Table 94. Gaplast GmbH Recent Developments
Table 95. Gerresheimer Basic Information
Table 96. Gerresheimer Ophthalmic Drug Delivery Device Product Overview
Table 97. Gerresheimer Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Gerresheimer Business Overview
Table 99. Gerresheimer Recent Developments
Table 100. Nemera Basic Information
Table 101. Nemera Ophthalmic Drug Delivery Device Product Overview
Table 102. Nemera Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Nemera Business Overview
Table 104. Nemera Recent Developments
Table 105. Nipro Corporation Basic Information
Table 106. Nipro Corporation Ophthalmic Drug Delivery Device Product Overview
Table 107. Nipro Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Nipro Corporation Business Overview
Table 109. Nipro Corporation Recent Developments
Table 110. Ocular Therapeutix Basic Information
Table 111. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Overview
Table 112. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Ocular Therapeutix Business Overview
Table 114. Ocular Therapeutix Recent Developments
Table 115. Owen Mumford Basic Information
Table 116. Owen Mumford Ophthalmic Drug Delivery Device Product Overview
Table 117. Owen Mumford Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Owen Mumford Business Overview
Table 119. Owen Mumford Recent Developments
Table 120. Silgan Holdings Inc. Basic Information
Table 121. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Overview
Table 122. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Silgan Holdings Inc. Business Overview
Table 124. Silgan Holdings Inc. Recent Developments
Table 125. Terumo Corporation Basic Information
Table 126. Terumo Corporation Ophthalmic Drug Delivery Device Product Overview
Table 127. Terumo Corporation Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Terumo Corporation Business Overview
Table 129. Terumo Corporation Recent Developments
Table 130. West Pharmaceutical Services, Inc. Basic Information
Table 131. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 132. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. West Pharmaceutical Services, Inc. Business Overview
Table 134. West Pharmaceutical Services, Inc. Recent Developments
Table 135. Kedalion Therapeutics Basic Information
Table 136. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Overview
Table 137. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Kedalion Therapeutics Business Overview
Table 139. Kedalion Therapeutics Recent Developments
Table 140. Re-Vana Therapeutics Basic Information
Table 141. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Overview
Table 142. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Re-Vana Therapeutics Business Overview
Table 144. Re-Vana Therapeutics Recent Developments
Table 145. Mati Therapeutics, Inc., Basic Information
Table 146. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Overview
Table 147. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Mati Therapeutics, Inc., Business Overview
Table 149. Mati Therapeutics, Inc., Recent Developments
Table 150. Biocorp Production Basic Information
Table 151. Biocorp Production Ophthalmic Drug Delivery Device Product Overview
Table 152. Biocorp Production Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Biocorp Production Business Overview
Table 154. Biocorp Production Recent Developments
Table 155. Ocumedic, Inc. Basic Information
Table 156. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Overview
Table 157. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Ocumedic, Inc. Business Overview
Table 159. Ocumedic, Inc. Recent Developments
Table 160. Global Ophthalmic Drug Delivery Device Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global Ophthalmic Drug Delivery Device Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific Ophthalmic Drug Delivery Device Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific Ophthalmic Drug Delivery Device Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa Ophthalmic Drug Delivery Device Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa Ophthalmic Drug Delivery Device Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global Ophthalmic Drug Delivery Device Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global Ophthalmic Drug Delivery Device Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global Ophthalmic Drug Delivery Device Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global Ophthalmic Drug Delivery Device Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global Ophthalmic Drug Delivery Device Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Ophthalmic Drug Delivery Device
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Ophthalmic Drug Delivery Device Market Size (M USD), 2025-2035
Figure 5. Global Ophthalmic Drug Delivery Device Market Size (M USD) (2020-2035)
Figure 6. Global Ophthalmic Drug Delivery Device Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Ophthalmic Drug Delivery Device Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Ophthalmic Drug Delivery Device Product Life Cycle
Figure 13. Ophthalmic Drug Delivery Device Sales Share by Manufacturers in 2025
Figure 14. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers in 2025
Figure 15. Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Ophthalmic Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Ophthalmic Drug Delivery Device Revenue in 2025
Figure 18. Industry Chain Map of Ophthalmic Drug Delivery Device
Figure 19. Global Ophthalmic Drug Delivery Device Market PEST Analysis
Figure 20. Global Ophthalmic Drug Delivery Device Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Ophthalmic Drug Delivery Device Market Share by Type
Figure 27. Sales Market Share of Ophthalmic Drug Delivery Device by Type (2020-2025)
Figure 28. Sales Market Share of Ophthalmic Drug Delivery Device by Type in 2025
Figure 29. Market Share of Ophthalmic Drug Delivery Device by Type (2020-2025)
Figure 30. Market Share of Ophthalmic Drug Delivery Device by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Ophthalmic Drug Delivery Device Market Share by Application
Figure 33. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2025)
Figure 34. Global Ophthalmic Drug Delivery Device Sales Market Share by Application in 2025
Figure 35. Global Ophthalmic Drug Delivery Device Market Share by Application (2020-2025)
Figure 36. Global Ophthalmic Drug Delivery Device Market Share by Application in 2025
Figure 37. Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
Figure 38. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2025)
Figure 39. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025)
Figure 40. North America Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 43. North America Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 45. U.S. Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Ophthalmic Drug Delivery Device Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Ophthalmic Drug Delivery Device Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Ophthalmic Drug Delivery Device Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Ophthalmic Drug Delivery Device Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 53. Europe Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 55. Germany Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Ophthalmic Drug Delivery Device Sales Market Share by Region in 2024
Figure 67. Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region in 2024
Figure 68. China Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 79. South America Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 80. South America Ophthalmic Drug Delivery Device Market Size and Growth Rate (M USD)
Figure 81. South America Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 82. Brazil Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Ophthalmic Drug Delivery Device Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region in 2024
Figure 92. Saudi Arabia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Ophthalmic Drug Delivery Device Production Market Share by Region (2020-2025)
Figure 103. North America Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 106. China Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Ophthalmic Drug Delivery Device Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Ophthalmic Drug Delivery Device Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Ophthalmic Drug Delivery Device Market Share Forecast by Type (2026-2035)
Figure 111. Global Ophthalmic Drug Delivery Device Sales Forecast by Application (2026-2035)
Figure 112. Global Ophthalmic Drug Delivery Device Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Ophthalmic Drug Delivery Device
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Ophthalmic Drug Delivery Device Market Size (M USD), 2025-2035
Figure 5. Global Ophthalmic Drug Delivery Device Market Size (M USD) (2020-2035)
Figure 6. Global Ophthalmic Drug Delivery Device Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Ophthalmic Drug Delivery Device Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Ophthalmic Drug Delivery Device Product Life Cycle
Figure 13. Ophthalmic Drug Delivery Device Sales Share by Manufacturers in 2025
Figure 14. Global Ophthalmic Drug Delivery Device Revenue Share by Manufacturers in 2025
Figure 15. Ophthalmic Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Ophthalmic Drug Delivery Device Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Ophthalmic Drug Delivery Device Revenue in 2025
Figure 18. Industry Chain Map of Ophthalmic Drug Delivery Device
Figure 19. Global Ophthalmic Drug Delivery Device Market PEST Analysis
Figure 20. Global Ophthalmic Drug Delivery Device Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Ophthalmic Drug Delivery Device Market Share by Type
Figure 27. Sales Market Share of Ophthalmic Drug Delivery Device by Type (2020-2025)
Figure 28. Sales Market Share of Ophthalmic Drug Delivery Device by Type in 2025
Figure 29. Market Share of Ophthalmic Drug Delivery Device by Type (2020-2025)
Figure 30. Market Share of Ophthalmic Drug Delivery Device by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Ophthalmic Drug Delivery Device Market Share by Application
Figure 33. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2020-2025)
Figure 34. Global Ophthalmic Drug Delivery Device Sales Market Share by Application in 2025
Figure 35. Global Ophthalmic Drug Delivery Device Market Share by Application (2020-2025)
Figure 36. Global Ophthalmic Drug Delivery Device Market Share by Application in 2025
Figure 37. Global Ophthalmic Drug Delivery Device Sales Growth Rate by Application (2020-2025)
Figure 38. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2020-2025)
Figure 39. Global Ophthalmic Drug Delivery Device Market Size by Region (2020-2025)
Figure 40. North America Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 43. North America Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 45. U.S. Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Ophthalmic Drug Delivery Device Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Ophthalmic Drug Delivery Device Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Ophthalmic Drug Delivery Device Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Ophthalmic Drug Delivery Device Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 53. Europe Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 55. Germany Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Ophthalmic Drug Delivery Device Sales Market Share by Region in 2024
Figure 67. Asia Pacific Ophthalmic Drug Delivery Device Market Size by Region in 2024
Figure 68. China Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 79. South America Ophthalmic Drug Delivery Device Sales Market Share by Country in 2024
Figure 80. South America Ophthalmic Drug Delivery Device Market Size and Growth Rate (M USD)
Figure 81. South America Ophthalmic Drug Delivery Device Market Size by Country in 2024
Figure 82. Brazil Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Ophthalmic Drug Delivery Device Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Ophthalmic Drug Delivery Device Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Ophthalmic Drug Delivery Device Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Ophthalmic Drug Delivery Device Market Size by Region in 2024
Figure 92. Saudi Arabia Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Ophthalmic Drug Delivery Device Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Ophthalmic Drug Delivery Device Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Ophthalmic Drug Delivery Device Production Market Share by Region (2020-2025)
Figure 103. North America Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 106. China Ophthalmic Drug Delivery Device Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Ophthalmic Drug Delivery Device Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Ophthalmic Drug Delivery Device Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Ophthalmic Drug Delivery Device Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Ophthalmic Drug Delivery Device Market Share Forecast by Type (2026-2035)
Figure 111. Global Ophthalmic Drug Delivery Device Sales Forecast by Application (2026-2035)
Figure 112. Global Ophthalmic Drug Delivery Device Market Share Forecast by Application (2026-2035)
